Erika Carmel-Tech Ltd (TLV:ERKA)
Israel · Delayed Price · Currency is ILS · Price in ILA 19.70
-0.90 (-4.37%)
At close: Feb 25, 2026
Erika Carmel-Tech Market Cap
Erika Carmel-Tech has a market cap or net worth of 20.52 million as of February 26, 2026. Its market cap has decreased by -18.60% in one year.
Market Cap
20.52M
Enterprise Value
17.94M
Revenue
39.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.70
Market Cap Chart
Since August 1, 2021, Erika Carmel-Tech's market cap has decreased from 645.68M to 20.52M, a decrease of -96.82%. That is a compound annual growth rate of -52.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 20.52M | 3.68% |
| Dec 31, 2025 | 19.79M | -20.83% |
| Dec 31, 2024 | 25.00M | -25.00% |
| Dec 27, 2023 | 33.33M | 59.16% |
| Dec 29, 2022 | 20.94M | -95.54% |
| Dec 30, 2021 | 470.07M | -27.20% |
| Aug 1, 2021 | 645.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 121.02B |
| Danel (Adir Yeoshua) | 2.66B |
| Kamada | 1.65B |
| BrainsWay | 1.48B |
| Nextage Therapeutics | 26.25M |
| Evogene | 22.88M |
| Bio-View | 21.31M |
| XTL Biopharmaceuticals | 20.82M |